The leaders of the Senate Health, Education, Labor and Pensions have released draft healthcare legislation for comment. The Lower Health Care Costs Act of 2019 contains five titles, one of which is titled Lowering the Costs of Prescription Drugs. This title contains sections meant to speed the introduction of biosimilars to the the market; to reduce abuses of citizen petitions to block generic entry; to enhance the transparency of IP for biologics through changes to the Purple Book; and to "modernize" the Orange Book.